The FDA approved the KAMRA inlay, a device implanted in the cornea of one eye to improve near vision in certain patients with presbyopia.
The KAMRA inlay is an opaque, ring-shaped device intended for use in patients 45 to 60 years old who, in addition to not having had cataract surgery, are unable to focus clearly on near objects or small print and need reading glasses with +1.00 to +2.50 diopters of power, but do not need glasses, or contacts for clear distance vision.
It is the first implantable device for correction of near vision in patients who have not had cataract surgery.
The device works by blocking unfocused light rays entering the eye in order to improve near vision. It blocks peripheral light rays while allowing central light rays to pass through a small opening in the center of the device, making near objects and small print less blurry.
